Pages that link to "Q28076453"

The following pages link to Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC) (Q28076453):

Displayed 14 items.

• Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia (Q41348351) ‎ (← links)
• Cholangitis: Diagnosis, Treatment and Prognosis (Q47137991) ‎ (← links)
• Therapeutic potential of phages in autoimmune liver diseases (Q47269751) ‎ (← links)
• Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. (Q53136572) ‎ (← links)
• Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems (Q57106957) ‎ (← links)
• Diagnostic and therapeutic potentials of microRNAs in cholangiopathies (Q57128794) ‎ (← links)
• Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver? (Q58729616) ‎ (← links)
• The gut-liver axis and the intersection with the microbiome (Q88634168) ‎ (← links)
• Publisher Correction: The gut-liver axis and the intersection with the microbiome (Q88764776) ‎ (← links)
• The role of the gut microbiome in chronic liver disease: the clinical evidence revised (Q89624002) ‎ (← links)
• Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology (Q90461761) ‎ (← links)
• Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either (Q91611230) ‎ (← links)
• Autoimmune liver disease and the enteric microbiome (Q91788029) ‎ (← links)
• Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota (Q91919553) ‎ (← links)